Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Experts say a healthy vaginal microbiome may cut down one's risk of infections like HPV in check. Probiotics can balance pH, ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

A new research paper was published in Oncoscience's Volume 12 on January 20, 2025, titled "Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database." ...

Angeline Usanase, 75, first learned she had cervical cancer in October 2017. When the doctor gave her the diagnosis, she couldn’t believe it. Seeking confirmation, she visited another doctor, who told ...

4 years have passed, and some high-income countries (eg, Australia, Sweden, and the UK) are on the threshold of attaining a cervical cancer incidence of four or fewer cases per 100 000 women-years.

Cervical cancer is caused by persistent infection due to human papillomavirus (HPV), leading to abnormal cell formation in the cervix. Some of the common symptoms of cervical cancer are vaginal ...

Cervical cancer, the fourth most common cancer in women, is closely linked to persistent HPV infections. Early detection through Pap smears and HPV testing can significantly reduce mortality.